Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arvinas Holding Company LLC

8.60
+0.950012.42%
Post-market: 8.620.0200+0.23%19:56 EDT
Volume:3.19M
Turnover:26.35M
Market Cap:591.44M
PE:-3.11
High:8.64
Open:7.74
Low:7.61
Close:7.65
Loading ...

Arvinas Initiated at Overweight by Stephens & Co.

Dow Jones
·
18 Nov 2024

Arvinas initiated with an Overweight at Stephens

TIPRANKS
·
18 Nov 2024

Analysts Are Bullish on These Healthcare Stocks: Arvinas Holding Company (ARVN), 2seventy bio (TSVT)

TIPRANKS
·
05 Nov 2024

Arvinas to Participate in Upcoming Investor Conferences

GlobeNewswire
·
04 Nov 2024

Arvinas Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
01 Nov 2024

UBS Adjusts Price Target on Arvinas to $74 From $82, Maintains Buy Rating

MT Newswires Live
·
31 Oct 2024

Stock Track | Arvinas Stock Plunges as Investors Remain Cautious Ahead of Pivotal Trial Results

Stock Track
·
31 Oct 2024

Arvinas Price Target Maintained With a $87.00/Share by HC Wainwright & Co.

Dow Jones
·
31 Oct 2024

Arvinas Inc : Leerink Partners Cuts Target Price to $64 From $65

THOMSON REUTERS
·
31 Oct 2024

Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Promising ...

GuruFocus.com
·
31 Oct 2024

Arvinas Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
30 Oct 2024

Arvinas' Q3 Net Loss Narrows, Revenue Rises

MT Newswires Live
·
30 Oct 2024

Stock Track | Arvinas Stock Soars 8.95% Pre-Market Despite Revenue Miss on Robust Earnings Beat

Stock Track
·
30 Oct 2024

Arvinas, Inc. (ARVN) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
30 Oct 2024

Arvinas Q3 2024 GAAP EPS $(0.68) Beats $(0.95) Estimate, Sales $102.400 Miss $57.421M Estimate

Benzinga
·
30 Oct 2024

Arvinas Q3 Operating Expenses USD 162.7 Million

THOMSON REUTERS
·
30 Oct 2024

Arvinas Q3 Basic EPS USD -0.68 VS. Ibes Estimate USD -0.96

THOMSON REUTERS
·
30 Oct 2024

Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
30 Oct 2024

We're Hopeful That Arvinas (NASDAQ:ARVN) Will Use Its Cash Wisely

Simply Wall St.
·
25 Oct 2024

Arvinas (ARVN): A Small-Cap Biotech with High Growth Potential

Insider Monkey
·
23 Oct 2024